Clinical Trial: A Study of Lutetium [177Lu] BL-ARC001 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors

U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07232407) titled 'A Study of Lutetium [177Lu] BL-ARC001 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors' on Nov. 14.

Brief Summary: This study is an open-label, multicenter, non-randomized Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetic profile, and preliminary efficacy of Lutetium [177Lu] BL-ARC001 in patients with locally advanced or metastatic solid tumors.

Study Start Date: Dec., 2025

Study Type: INTERVENTIONAL

Condition: Gastrointestinal Tumors Solid Tumors

Intervention: DRUG: Lutetium [177Lu] BL-ARC001

Administration by intravenous infusion for a cycle of 6 weeks...